🇺🇸 FDA

Intelligence · Clinical Pipeline

Sinovac Research and Pipeline

All ClinicalTrials.gov programs at Sinovac Research and — phase, modality, and trial IDs.

Programs
115

Quick answer

Sinovac Research and has 115 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. 36-71 months old children-experimental EV71 vaccine.

    Sinovac Research and Development Co.,

    Hand, Foot and Mouth Disease

    phase 3 mab completed

    1 trial

  2. 400U /0.5ml EV71 vaccine

    Sinovac Research and Development Co.,

    Hand, Foot and Mouth Disease

    phase 3 mab completed

    1 trial

  3. Adsorbed COVID-19 (inactivated) Vaccine

    Sinovac Research and Development Co.,

    COVID-19

    phase 3 mab completed

    1 trial

  4. COVID-19 Vaccine (Vero cell), Inactivated (Omicron variant)

    Sinovac Research and Development Co.,

    COVID-19

    phase 3 mab completed

    1 trial

  5. COVID-19 Vaccine,Inactivated

    Sinovac Research and Development Co.,

    COVID-19

    phase 3 mab completed

    1 trial

  6. Experimental vaccine

    Sinovac Research and Development Co.,

    Poliomyelitis

    phase 3 mab completed

    1 trial

  7. Inactivated COVID-19 Vaccine

    Sinovac Research and Development Co.,

    COVID-19

    phase 3 mab completed

    4 trials

  8. Influenza Vaccine (Split Virion), Inactivated, Quadrivalent

    Sinovac Research and Development Co.,

    Seasonal Influenza

    phase 3 mab completed

    1 trial

  9. Investigational live attenuated mumps vaccine

    Sinovac Research and Development Co.,

    Mumps

    phase 3 mab completed

    2 trials

  10. Investigational sIPV

    Sinovac Research and Development Co.,

    Poliomyelitis

    phase 3 mab completed

    1 trial

  11. Investigational tetanus vaccine, adsorbed

    Sinovac Research and Development Co.,

    Tetanus

    phase 3 mab completed

    1 trial

  12. Live attenuated varicella vaccines manufactured by Sinovac (Dalian) Vaccine Technology Co., Ltd

    Sinovac Research and Development Co.,

    Varicella

    phase 3 mab active

    1 trial

  13. Medium-dosage COVID-19 Vaccine,Inactivated

    Sinovac Research and Development Co.,

    COVID-19

    phase 3 mab terminated

    1 trial

  14. PROVARIX

    Sinovac Research and Development Co.,

    Varicella (Chickenpox)

    phase 3 mab active

    1 trial

  15. Participants will receive one dose of vaccine (0.5 mL) of Sinovac QIV

    Sinovac Research and Development Co.,

    Influenza

    phase 3 mab active

    1 trial

  16. Quadrivalent influenza vaccine

    Sinovac Research and Development Co.,

    Seasonal Influenza

    phase 3 mab completed

    2 trials

  17. Quadrivalent influenza vaccine(0.25ml)

    Sinovac Research and Development Co.,

    Seasonal Influenza

    phase 3 mab completed

    2 trials

  18. Rabies Vaccine (Serum-free Vero Cell), Freeze-dried

    Sinovac Research and Development Co.,

    Rabies

    phase 3 mab active

    2 trials

  19. Rabies vaccine

    Sinovac Research and Development Co.,

    Rabies (Healthy Volunteers)

    phase 3 mab active

    1 trial

  20. SARS-CoV-2 inactivated vaccine

    Sinovac Research and Development Co.,

    Covid19

    phase 3 mab completed

    1 trial

  21. SARS-CoV-2 vaccine (inactivated)

    Sinovac Research and Development Co.,

    SARS-CoV2 Infection

    phase 3 mab completed

    1 trial

  22. Sabin Strain Inactivated Poliovirus Vaccine

    Sinovac Research and Development Co.,

    Poliomyelitis

    phase 3 mab completed

    1 trial

  23. Sinovac PCV13

    Sinovac Research and Development Co.,

    Pneumococcal Infectious Diseases

    phase 3 mab active

    1 trial

  24. Sinovac PCV13

    Sinovac Research and Development Co.,

    Pneumococcal Infectious Disease

    phase 3 mab active

    2 trials

  25. Sinovac rabies vaccine

    Sinovac Research and Development Co.,

    Rabies (Healthy Volunteers)

    phase 3 mab active

    2 trials

  26. Tetravalent influenza vaccine developed by Sinovac Biotech Co.

    Sinovac Research and Development Co.,

    Influenza

    phase 3 small molecule active

    1 trial

  27. Three doses of experimental sIPV of lot 1 at the schedule of 2,3,4 months of age

    Sinovac Research and Development Co.,

    Poliomyelitis

    phase 3 mab completed

    1 trial

  28. Trivalent COVID-19 Vaccine (Vero Cell), Inactivated, Prototype Strain, Delta Strain and Omicron Strain

    Sinovac Research and Development Co.,

    COVID-19

    phase 3 mab active

    1 trial

  29. Two doses of commercial scale inactivated SARS-CoV-2 vaccine at the schedule of day 0,14

    Sinovac Research and Development Co.,

    Covid19

    phase 3 mab completed

    1 trial

  30. Vaccine manufactured at commercialized scale

    Sinovac Research and Development Co.,

    Varicella

    phase 3 mab completed

    1 trial

  31. Varicella Vaccine

    Sinovac Research and Development Co.,

    Varicella

    phase 3 mab completed

    1 trial

  32. Varicella Vaccine

    Sinovac Research and Development Co.,

    Varicella (Chickenpox)

    phase 3 mab active

    1 trial

  33. bivalent enterovirus vaccine (Vero cell), inactivated

    Sinovac Research and Development Co.,

    Hand, Foot, and Mouth Disease（HFMD)

    phase 3 mab active

    1 trial

  34. experimental vaccine

    Sinovac Research and Development Co.,

    Epidemic Meningitis

    phase 3 mab active

    4 trials

  35. sIPV-bOPV-bOPV vaccination schedule

    Sinovac Research and Development Co.,

    Poliomyelitis

    phase 3 mab completed

    1 trial

  36. sIPV-sIPV-bOPV vaccination schedule

    Sinovac Research and Development Co.,

    Poliomyelitis

    phase 3 mab completed

    1 trial

  37. three consecutive lots of EV71 vaccine

    Sinovac Research and Development Co.,

    Hand, Foot and Mouth Disease

    phase 3 mab completed

    1 trial

  38. 100U EV71 vaccine with adjuvant

    Sinovac Research and Development Co.,

    Infection, Viral, Enterovirus

    phase 2 mab completed

    1 trial

  39. 400 U EV71 vaccine with adjuvant

    Sinovac Research and Development Co.,

    Infection, Viral, Enterovirus

    phase 2 mab terminated

    1 trial

  40. COVID-19 Vaccine (Vero Cell), Inactivated (Medium-dose)

    Sinovac Research and Development Co.,

    COVID-19

    phase 2 mab terminated

    1 trial

  41. COVID-19 Vaccine (Vero Cell), Inactivated, Omicron Strain

    Sinovac Research and Development Co.,

    COVID-19

    phase 2 mab completed

    1 trial

  42. CoronaVac®

    Sinovac Research and Development Co.,

    COVID-19

    phase 2 mab completed

    1 trial

  43. Low-dose experimental vaccine

    Sinovac Research and Development Co.,

    Herpes Zoster

    phase 2 mab active

    1 trial

  44. Low-dose of tetravalent inactivated enterovirus vaccine (Vero cell)

    Sinovac Research and Development Co.,

    Hand, Foot, and Mouth Disease (HFMD)

    phase 2 mab completed

    1 trial

  45. Medium-dose COVID-19 Vaccine(Vero Cell),Inactivated

    Sinovac Research and Development Co.,

    COVID-19

    phase 2 mab on hold

    1 trial

  46. Oral hexavalent reassortant rotavirus attenuated live vaccine

    Sinovac Research and Development Co.,

    Rotavirus Gastroenteritis

    phase 2 mab active

    2 trials

  47. SA55 Injection

    Sinovac Research and Development Co.,

    Infection of Upper Respiratory Tract Caused by 2019-nCoV

    phase 2 small molecule active

    1 trial

  48. SNA02-48

    Sinovac Research and Development Co.,

    Tetanus

    phase 2 mab active

    1 trial

Frequently asked questions

How many pipeline programs does Sinovac Research and have?

115 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.